UBS analyst Brennan Hawken lowered the firm’s price target on Ameriprise to $495 from $500 and keeps a Buy rating on the shares. Data points continue to support a capital markets recovery, while wealth management multiples have recovered, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMP: